Correlation Between XSpray Pharma and Vicore Pharma
Can any of the company-specific risk be diversified away by investing in both XSpray Pharma and Vicore Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XSpray Pharma and Vicore Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XSpray Pharma AB and Vicore Pharma Holding, you can compare the effects of market volatilities on XSpray Pharma and Vicore Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XSpray Pharma with a short position of Vicore Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of XSpray Pharma and Vicore Pharma.
Diversification Opportunities for XSpray Pharma and Vicore Pharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between XSpray and Vicore is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding XSpray Pharma AB and Vicore Pharma Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vicore Pharma Holding and XSpray Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XSpray Pharma AB are associated (or correlated) with Vicore Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vicore Pharma Holding has no effect on the direction of XSpray Pharma i.e., XSpray Pharma and Vicore Pharma go up and down completely randomly.
Pair Corralation between XSpray Pharma and Vicore Pharma
If you would invest 4,030 in XSpray Pharma AB on September 24, 2024 and sell it today you would earn a total of 210.00 from holding XSpray Pharma AB or generate 5.21% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.6% |
Values | Daily Returns |
XSpray Pharma AB vs. Vicore Pharma Holding
Performance |
Timeline |
XSpray Pharma AB |
Vicore Pharma Holding |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Modest
XSpray Pharma and Vicore Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with XSpray Pharma and Vicore Pharma
The main advantage of trading using opposite XSpray Pharma and Vicore Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XSpray Pharma position performs unexpectedly, Vicore Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vicore Pharma will offset losses from the drop in Vicore Pharma's long position.XSpray Pharma vs. BioInvent International AB | XSpray Pharma vs. Alligator Bioscience AB | XSpray Pharma vs. Moberg Pharma AB | XSpray Pharma vs. Oncopeptides AB |
Vicore Pharma vs. JLT Mobile Computers | Vicore Pharma vs. SaltX Technology Holding | Vicore Pharma vs. Havsfrun Investment AB | Vicore Pharma vs. Beowulf Mining PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |